On ECHEMI
Home > Drugs > Metformin hydrochloride Registered Holders
Metformin hydrochloride structure

Metformin hydrochloride structure

Metformin hydrochloride

Metformin (hydrochloride) is an FDA approved first-line drug for the treatment of type 2 diabetes. Metformin decreases hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory-chain complex 1.

Find 58 Related Holders

Shandong Keyuan Pharmaceutical Co.,Ltd.
Japan Japan

API Registration Country

API Active
SHOUGUANG FUKANG PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
ABHILASHA PHARMA PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
SHIJIAZHUANG CREADY PHARMACEUTICAL R AND D INC
United States United States

API Registration Country

API Active
SHANDONG LURUI PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
Wanbury Limited
European Union European Union

API Registration Country

API Active
TRIMAX BIO SCIENCES PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
MACLEODS PHARMACEUTICALS LIMITED
European Union European Union

API Registration Country

API Active
APITORIA PHARMA PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
KUNSHAN DOUBLE CRANE PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Metformin hydrochloride
View 136 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.